文献速递神经头颈MR

多次注射线性钆对比剂后脑与颈髓T1加权MR图像上的信号高信号

Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-07-25

单中心100例多发性硬化患者接受2-16次增强MRI,比较首次与末次扫描信号强度比。接受≥6次线性钆对比剂注射者苍白球、齿状核、黑质信号强度比显著升高,且与注射次数及累积剂量正相关;颈髓未见显著变化。

要点

  • 多发性硬化患者多次线性钆对比剂注射后,苍白球、齿状核、黑质T1信号强度比升高。
  • 信号升高与注射次数和累积剂量正相关,≥6次注射者变化显著更高。
  • 颈髓信号强度比未见显著变化。

核心结论

  • 多发性硬化患者接受≥6次线性钆对比剂注射后,苍白球、齿状核和黑质信号强度显著升高,颈髓未检测到变化。

研究设计与样本

  • 单中心分析100例多发性硬化患者,接受2-16次增强MRI;50例接受≤5次线性钆注射,50例接受≥6次;52例同时接受Gd-DTPA和钆贝葡胺注射,48例仅接受钆贝葡胺;2名阅片者对首次和末次MRI独立进行信号强度定量分析。

关键影像表现/征象

  • 苍白球/丘脑信号强度比平均增加+0.0251±0.0432(P<.001)。
  • 齿状核/中小脑脚信号强度比平均增加+0.0266±0.0841(P=.002)。
  • 黑质/中脑信号强度比平均增加+0.0262±0.0673(P<.001)。
  • 颈髓/脑桥信号强度比平均增加+0.0008±0.0089(P=.400),无显著变化。

诊断标准与关键数值

  • 接受≥6次注射者苍白球/丘脑、齿状核/中小脑脚、黑质/中脑信号强度比变化显著高于接受≤5次者(P<.001)。
  • 信号强度比变化与注射次数及累积剂量正相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The clinical implications of gadolinium deposition in the CNS are not fully understood, and it is still not known whether gadolinium tends to be retained more in the brain compared with the spinal cord. In this study, we assessed the effects of linear gadolinium-based contrast agents on the T1 signal intensity of 3 cerebral areas (dentate nucleus, globus pallidus, and the less studied substantia nigra) and the cervical spinal cord in a population of patients with MS.

MATERIALS AND METHODS: A single-center population of 100 patients with MS was analyzed. Patients underwent 2-16 contrast-enhanced MRIs. Fifty patients received ≤5 linear gadolinium injections, and 50 patients had ≥6 injections: Fifty-two patients had both Gd-DTPA and gadobenate dimeglumine injections, and 48 patients received only gadobenate dimeglumine. A quantitative analysis of signal intensity changes was independently performed by 2 readers on the first and last MR imaging scan. The globus pallidus-to-thalamus, substantia nigra-to-midbrain, dentate nucleus-to-middle cerebellar peduncle, and the cervical spinal cord-to-pons signal intensity ratios were calculated.

RESULTS: An increase of globus pallidus-to-thalamus (mean, +0.0251 ± 0.0432; P < .001), dentate nucleus-to-middle cerebellar peduncle (mean, +0.0266 ± 0.0841; P = .002), and substantia nigra-to-midbrain (mean, +0.0262 ± 0.0673; P < .001) signal intensity ratios after multiple administrations of linear gadolinium-based contrast agents was observed. These changes were significantly higher in patients who received ≥6 injections (P < .001) and positively correlated with the number of injections and the accumulated dose of contrast. No significant changes were detected in the spinal cord (mean, +0.0008 ± 0.0089; P = .400).

CONCLUSIONS: Patients with MS receiving ≥6 linear gadolinium-based contrast agent injections showed a significant increase in the signal intensity of the globus pallidus, dentate nucleus, and substantia nigra; no detectable changes were observed in the cervical spinal cord.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Barisano G, Bigjahan B, Metting S, et al. Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent. AJNR Am J Neuroradiol. 2019. PMID: 31345942. doi:10.3174/ajnr.A6148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。